The Mechanism of Action of Qihuang Jiangtang Capsule in the Treatment of Type 2 Diabetes Based on Network Pharmacology and Molecular Docking Technology

Abstract

Objective Our objective was to investigate the potential mechanism of action of Qihuang Jiangtang capsule (QHJTC) in the treatment of type 2 diabetes mellitus (T2DM) through network pharmacology and molecular docking.

Methods The active components of materia medica in the formula of QHJTC were searched on the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform and Encyclopedia of Traditional Chinese Medicine. The targets related to the active components were obtained via PubChem database. The targets related to T2DM were retrieved through the GeneCards database. The targets corresponding to the active components and diabetes mellitus were uploaded to the Venn diagrams website to get the Venn diagram, and the intersecting targets were the potential targets of QHJTC in treating T2DM. The active components and potential targets were imported into Cytoscape 3.7.2 software to construct the active component–potential target network, and the key compounds and targets were screened by the Network Analyzer module in the Tools module. The potential targets were imported into the STRING database to obtain the interaction relationships, so as to analyze and construct the protein–protein interaction (PPI) network by Cytoscape 3.7.2 software. The intersecting targets were introduced into Metascape for gene ontology (GO) functional enrichment analysis and Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis. The top 20 signaling pathways obtained by the KEGG pathway enrichment analysis and the related targets and the corresponding targets were analyzed by using Cytoscape 3.7.2 software to construct the “active component–important target-key pathway network ” for the intervention of T2DM with QHJTC. The molecular docking of active components and core targets was performed with AutoDock software.

Results A total of 237 active components and 281 related targets were obtained from QHJTC, as well as 1 362 T2DM targets and 155 potential targets of QHJTC in treating T2DM. There were 32 key components and 49 key targets identified by the active component–potential target network topology analysis. There were 471 terms obtained from GO functional enrichment analysis, among which 248 related to biological processes, 125 related to molecular functions, and 98 related to cellular components. There were 299 signaling pathways obtained from KEGG pathway enrichment analysis. The active components of QHJTC were found spontaneously binding to the core targets.

Conclusions QHJTC can treat T2DM through multi-components, multi-targets, and multi-pathways.

Keywords

type 2 diabetes mellitus - Qihuang Jiangtang capsule - network pharmacology - molecular docking - mechanism of action

CRediT Authorship Contribution Statement

Ji Mengmeng: Analyzing the data and wrote the draft manuscript. Yanan Yu, Jiarui Wu, Jun Liu, Yanhua Jiang: Providing technical support, revised the manuscript. Zhiwei Jing: Designing the study, directed and financially supported the study and revising the manuscript.

Publikationsverlauf

Eingereicht: 26. März 2022

Angenommen: 02. Mai 2022

Artikel online veröffentlicht:
27. Oktober 2022

• References

• 1 Wang X, Strizich G, Hu Y, Wang T, Kaplan RC, Qi Q. Genetic markers of type 2 diabetes: progress in genome-wide association studies and clinical application for risk prediction. J Diabetes 2016; 8 (01) 24-35
• 2 Chinese Diabetes Society. Guideline for the prevention and treatment of type 2 diabetes mellitus in China (2020 edition). Chin J Diabetes Mellitus 2021; 13 (04) 315-409
• 3 Hu C, Jia W. Diabetes in China: epidemiology and genetic risk factors and their clinical utility in personalized medication. Diabetes 2018; 67 (01) 3-11
• 4 Qiao GQ. Chinese medicine powder for treating diabetes: CN101406627A[P]. 2009–04–15.
• 5 Ru J, Li P, Wang J. et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 2014; 6: 13
• 6 Xu HY, Zhang YQ, Liu ZM. et al. ETCM: an encyclopaedia of traditional Chinese medicine. Nucleic Acids Res 2019; 47 (D1): D976-D982
• 7 Chinese Pharmacopoeia Commission. Pharmocopoedia of the People's Republic of China: 2005 ed. Peking: Chemical Industry Press Co., Ltd.; 2005: 63
• 8 Li XZ, Wang XX. Determination of trace element content in gypsum of different origins. Zhong Yao Cai 1990; 13 (04) 35-36
• 9 Na Z, Zi-Jun S, Jian-Wu HE. et al. [Discovery and study on potential effect of herbal pair of Uncariae Ramulus cum Uncis-Eucommiae Cortex on pregnancy hypertension based on network pharmacology and molecular docking]. Zhongguo Zhongyao Zazhi 2020; 45 (22) 5393-5402
• 10 Huang GW, Chen FC, Liu Y. et al. Predictive analysis of active compounds in Qinsu Capsule for prevention of COVID-19 based on network pharmacology and molecular docking. Shanghai J Tradit Chin Med 2020; 54 (10) 1-11
• 11 Fan XT, Wu C, Li JL. et al. Research on the potential mechanism of Shiyi Qingwen Pill against COVID-19 based on network pharmacology and molecular docking. Lishizhen Med Mater Med Res 2021; 32 (01) 206-210
• 12 Chen YL, Sun ZL. Discussion on the identification and prevention and control strategies of the related ethnic specific risk factors in diabetic lifestyle. Chin J Diabetes Mellitus 2018; 10 (05) 310-313
• 13 Meng JQ. The effect of Renshen Baihu decoction in the treatment of type 2 diabetes mellitus and its mechanism. J Med Theory Pract 2018; 31 (10) 1455-1456
• 14 Chen WY, Yao ZY, Hu H. Clinical study on modified Xiaoke prescription for atherosclerotic disease of the lower extremities induced by type 2 diabetes with excessive heat impairing body fluid syndrome. J New Chin Med 2019; 51 (09) 122-124
• 15 Wu XM, Lin WY, Zhang YX. et al. Curative effect of Yu'nv deoction combined with Shashen Maidong Decoction on Yin-deficiency and fire-hyperactivity type diabetes mellitus and its influence on serum vaspin and omentin-1. J Sichuan Tradit Chin Med 2021; 39 (02) 113-116
• 16 Zhang L, Fang ZH. Research progress of Liuwei Dihuang pills in treating diabetes mellitus. Clin J Tradit Chin Med 2018; 30 (12) 2328-2331
• 17 Konheim YL, Wolford JK. Association of a promoter variant in the inducible cyclooxygenase-2 gene (PTGS2) with type 2 diabetes mellitus in Pima Indians. Hum Genet 2003; 113 (05) 377-381
• 18 Pinelli M, Giacchetti M, Acquaviva F. et al. Beta2-adrenergic receptor and UCP3 variants modulate the relationship between age and type 2 diabetes mellitus. BMC Med Genet 2006; 7: 85
• 19 Liu SW, Liu JY. Advances in the pharmacological effects of quercetin. Chin J Lung Dis Electron Ed 2020; 13 (01) 104-106
• 20 Ge L, Cai YJ, Wang ZD. Effect of quercetin on insulin resistance and FGF21/MAPK signaling pathway in type 2 diabetic rats. China Pharm 2019; 22 (03) 418-421
• 21 Ren L, Wang KJ, Zong Y. Mechanism of quercetin in treatment of type 2 diabetes mellitus based on network pharmacology and molecular docking method. Herb Eval Res 2020; 43 (10) 1964-1970
• 22 Sun FH, Wang QH, Qiu ZL. et al. Research progress of mechanisms of traditional Chinese medicine in treatment of insulin resistance of type 2 diabetes mellitus. Med Recapitul 2018; 24 (20) 4068-4072 , 4077
• 23 Teng JL, Su RR, Liu HL. et al. Clinical effect analysis of QHJTC on primary type 2 diabetes mellitus and its effect on islet function. Zhonghua Zhongyiyao Xuekan 2021; 39 (06) 236-239
• 24 Tang SM, Yang ZM, Chen WQ. et al. Astragalus polysaccharide improves type 2 diabetes mellitus in rats by protecting islet β cells. Acad J Second Mil Med Univ 2017; 38 (04) 482-487
• 25 Chen YY, Cui WW, Liu HL. et al. Effect of Qihuang Jiangtang Capsule on blood glucose regulation and pancreatic tissue in diabetes model rats. Chin J Tradit Chin Med 2021 Accessed September 06, 2022, at: https://kns.cnki.net/kcms/detail/21.1546.R.20211203.2033.042.html
• 26 Yang CM, Yang ZX, Ma XL. The mechanism of AGEs-RAGE signaling pathway in diabetic nephropathy and the progress of Chinese medicine treatment. Acta Chin Med 2019; 34 (09) 1864-1868